BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3904801)

  • 21. Detection of ras gene alterations and ras proteins in colorectal cancer.
    Salhab N; Jones DJ; Bos JL; Kinsella A; Schofield PF
    Dis Colon Rectum; 1989 Aug; 32(8):659-64. PubMed ID: 2666051
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
    Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. K-ras exon 4A has a tumour suppressor effect on carcinogen-induced murine colonic adenoma formation.
    Luo F; Ye H; Hamoudi R; Dong G; Zhang W; Patek CE; Poulogiannis G; Arends MJ
    J Pathol; 2010 Apr; 220(5):542-50. PubMed ID: 20087880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated expression of the human ras oncogene family in premalignant and malignant tumours of the colorectum.
    Spandidos DA; Kerr IB
    Br J Cancer; 1984 Jun; 49(6):681-8. PubMed ID: 6733017
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical study of the ras oncogene expression in human breast lesions.
    Agnantis NJ; Petraki C; Markoulatos P; Spandidos DA
    Anticancer Res; 1986; 6(5):1157-60. PubMed ID: 3541779
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
    Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
    Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the nuclear oncogene p53 in colon tumours.
    van den Berg FM; Tigges AJ; Schipper ME; den Hartog-Jager FC; Kroes WG; Walboomers JM
    J Pathol; 1989 Mar; 157(3):193-9. PubMed ID: 2926561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cellular retinol-binding protein (CRBP) in human colorectal adenocarcinoma.
    Fex G; Ekelund G; Leandoer L; Sternby NH
    Br J Cancer; 1986 May; 53(5):687-90. PubMed ID: 3718824
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunohistochemical detection of ras p21 and c-myc p62 in colonic adenomas and carcinomas.
    Agnantis NJ; Apostolikas N; Sficas C; Zolota V; Spandidos DA
    Hepatogastroenterology; 1991 Jun; 38(3):239-42. PubMed ID: 1937363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Selective elevation of the N1-acetylspermidine level in human colorectal adenocarcinomas.
    Takenoshita S; Matsuzaki S; Nakano G; Kimura H; Hoshi H; Shoda H; Nakamura T
    Cancer Res; 1984 Feb; 44(2):845-7. PubMed ID: 6692383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases.
    Thor A; Horan Hand P; Wunderlich D; Caruso A; Muraro R; Schlom J
    Nature; 1984 Oct 11-17; 311(5986):562-5. PubMed ID: 6482968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of quantitative liquid competition radioimmunoassays for the ras oncogene and proto-oncogene p21 products.
    Caruso A; Schlom J; Vilasi V; Weeks MO; Hand PH
    Int J Cancer; 1986 Oct; 38(4):587-95. PubMed ID: 3489681
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DNA in situ sensitivity to denaturation: a new parameter for flow cytometry of normal human colonic epithelium and colon carcinoma.
    Kunicka JE; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1987 Aug; 47(15):3942-7. PubMed ID: 3607742
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
    Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G
    Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of ras oncogene product P21 in thyroid tumors: an immunohistochemical study].
    Gui K
    Zhonghua Yi Xue Za Zhi; 1990 Mar; 70(3):140-2, 12. PubMed ID: 2163739
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Immunohistochemical studies of ras oncogene product p21 in human ovarian tumors].
    Yaginuma Y; Yamashita K
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Sep; 41(9):1409-16. PubMed ID: 2685141
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of ras oncogene p21 during human fetal development as determined by monoclonal antibodies RAP-5, Y13-259, and DWP.
    Radosevich JA; Combs SG; Ma Y; Lee I; Gould VE; Thor A; Schlom J; Carney WP; Rosen ST
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1989; 56(5):337-44. PubMed ID: 2565631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A microphotometric study on the nuclear DNA content in cells of human and experimental large intestinal carcinoma].
    Hasegawa H
    Nihon Geka Hokan; 1985 Nov; 54(6):486-97. PubMed ID: 3834865
    [No Abstract]   [Full Text] [Related]  

  • 39. [Detection of the expression of P21, P53, P185 proteins and the mutation of ras, p53 genes in colorectal adenoma and carcinoma].
    Liang Z; Liu F; Luo Y
    Zhonghua Bing Li Xue Za Zhi; 1995 Dec; 24(6):352-5. PubMed ID: 8732090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.